Potential enhancing effects of histamine H1 agonism/H 3 antagonism on working memory assessed by performance and bold response in healthy volunteers

British Journal of Pharmacology

Volumn 170, Issue 1, 2013, Pages 144-155

  Van Ruitenbeek, P ^a,b   Mehta, M A ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

betahistine; H1 agonist; H3 antagonist; histamine; human cognition; imaging; learning; memory; MRI

Indexed keywords

BETAHISTINE; HISTAMINE H1 RECEPTOR; PLACEBO;

ADULT; ARTICLE; BRAIN FUNCTION; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG MECHANISM; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; LATERAL GENICULATE BODY; LEARNING; MALE; MENTAL PERFORMANCE; MENTAL TASK; NERVE CELL NETWORK; NEUROIMAGING; NORMAL HUMAN; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TASK PERFORMANCE; WORKING MEMORY;

BETAHISTINE; H1 AGONIST; H3 ANTAGONIST; HISTAMINE; HUMAN COGNITION; IMAGING; LEARNING; MEMORY; MRI;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; BETAHISTINE; BRAIN; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; HISTAMINE AGONISTS; HISTAMINE H3 ANTAGONISTS; HUMANS; LEARNING; MAGNETIC RESONANCE IMAGING; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; YOUNG ADULT;

EID: 84881622413     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12184     Document Type: Article

References (57)

1. Abi-Dargham A, Mawlawi O, Lombardo I, Gil R, Martinez D, Huang Y, et al. (2002). Prefrontal dopamine D1 receptors and working memory in schizophrenia. J Neurosci 22: 3708-3719.
2. Abi-Dargham A, Xu X, Thompson JL, Gil R, Kegeles LS, Urban N, et al. (2012). Increased prefrontal cortical D(1) receptors in drug naive patients with schizophrenia: a PET study with [(1)(1)C]NNC112. J Psychopharmacol 26: 794-805.
3. Arrang JM, (2007). Histamine and schizophrenia. Int Rev Neurobiol 78: 247-287.
4. Banqui Q, Banjar WMA, Gazzaz J, Hou RH, Langley RW, Szabadi E, et al. (2008). Comparison of betahistine and diphenhydramine on alertness and automatic functions in healthy volunteers. J Psychopharmacol 22 (5 Suppl.): A33.
5. Betts T, Harris D, Gadd E, (1991). The effects of two anti-vertigo drugs (betahistine and prochlorperazine) on driving skills. Br J Clin Pharmacol 32: 455-458.
6. Bor D, Duncan J, Wiseman RJ, Owen AM, (2003). Encoding strategies dissociate prefrontal activity from working memory demand. Neuron 37: 361-367.
7. Bor D, Cumming N, Scott CE, Owen AM, (2004). Prefrontal cortical involvement in verbal encoding strategies. Eur J Neurosci 19: 3365-3370.
8. Caceres A, Hall DL, Zelaya FO, Williams SC, Mehta MA, (2009). Measuring fMRI reliability with the intra-class correlation coefficient. Neuroimage 45: 758-768.
9. Chen XY, Zhong DF, Duan JL, Yan BX, (2003). LC-MS-MS analysis of 2-pyridylacetic acid, a major metabolite of betahistine: application to a pharmacokinetic study in healthy volunteers. Xenobiotica 33: 1261-1271.
10. Cinca R, (2010). Evaluation of safety, drug-drug interactions and pharmacokinetic profiles of co-administration of betahistine with olanzapine in healthy female subjects. OBEcure, Ltd.: Ramat Gan, Israel.
11. Davis KL, Kahn RS, Ko G, Davidson M, (1991). Dopamine in schizophrenia: a review and reconceptualization. Am J Psychiatry 148: 1474-1486.
12. Davis MH, Gaskell MG, (2009). A complementary systems account of word learning: neural and behavioural evidence. Philos Trans R Soc Lond B Biol Sci 364: 3773-3800.
13. Diaz MT, McCarthy G, (2009). A comparison of brain activity evoked by single content and function words: an fMRI investigation of implicit word processing. Brain Res 1282: 38-49.
14. Esbenshade TA, Browman KE, Bitner RS, Strakhova M, Cowart MD, Brioni JD, (2008). The histamine H3 receptor: an attractive target for the treatment of cognitive disorders. Br J Pharmacol 154: 1166-1181.
15. Fossati A, Barone D, Benvenuti C, (2001). Binding affinity profile of betahistine and its metabolites for central histamine receptors of rodents. Pharmacol Res 43: 389-392.
16. Gordon CR, Doweck I, Nachum Z, Gonen A, Spitzer O, Shupak A, (2003). Evaluation of betahistine for the prevention of seasickness: effect on vestibular function, psychomotor performance and efficacy at sea. J Vestib Res 13: 103-111.
17. Gould RL, Brown RG, Owen AM, Bullmore ET, Howard RJ, (2006). Task-induced deactivations during successful paired associates learning: an effect of age but not Alzheimer's disease. Neuroimage 31: 818-831.
18. Harvey PD, Green MF, Bowie C, Loebel A, (2006). The dimensions of clinical and cognitive change in schizophrenia: evidence for independence of improvements. Psychopharmacology (Berl) 187: 356-363.
19. Honey GD, Bullmore ET, Soni W, Varatheesan M, Williams SC, Sharma T, (1999). Differences in frontal cortical activation by a working memory task after substitution of risperidone for typical antipsychotic drugs in patients with schizophrenia. Proc Natl Acad Sci U S A 96: 13432-13437.
20. Ito C, (2004). The role of the central histaminergic system on schizophrenia. Drug News Perspect 17: 383-387.
21. Iwabuchi K, Ito C, Tashiro M, Kato M, Kano M, Itoh M, et al. (2005). Histamine H1 receptors in schizophrenic patients measured by positron emission tomography. Eur Neuropsychopharmacol 15: 185-191.
22. Jin CY, Anichtchik O, Panula P, (2009). Altered histamine H3 receptor radioligand binding in post-mortem brain samples from subjects with psychiatric diseases. Br J Pharmacol 157: 118-129.
23. Jonides J, Schumacher EH, Smith EE, Koeppe RA, Awh E, Reuter-Lorenz PA, et al. (1998). The role of parietal cortex in verbal working memory. J Neurosci 18: 5026-5034.
24. Kandel E, Schwartz JH, Jessell TM, (2000). Principles of Neural Science, 4th edn. McGraw-Hill: New-York.
25. Kawashima R, Inoue K, Sato K, Fukuda H, (1997). Functional asymmetry of cortical motor control in left-handed subjects. Neuroreport 8: 1729-1732.
26. Keefe RS, Fenton WS, (2007). How should DSM-V criteria for schizophrenia include cognitive impairment? Schizophr Bull 33: 912-920.
27. Kegeles LS, Abi-Dargham A, Frankle WG, Gil R, Cooper TB, Slifstein M, et al. (2010). Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67: 231-239.
28. Keshavan MS, Tandon R, Boutros NN, Nasrallah HA, (2008). Schizophrenia, 'just the facts': what we know in 2008 Part 3: neurobiology. Schizophr Res 106: 89-107.
29. Kuroki T, Meltzer HY, Ichikawa J, (1999). Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 288: 774-781.
30. Lawrence NS, Ross TJ, Hoffmann R, Garavan H, Stein EA, (2003). Multiple neuronal networks mediate sustained attention. J Cogn Neurosci 15: 1028-1038.
31. Ligneau X, Landais L, Perrin D, Piriou J, Uguen M, Denis E, et al. (2007). Brain histamine and schizophrenia: potential therapeutic applications of H(3)-receptor inverse agonists studied with BF2.649. Biochem Pharmacol 73: 1215-1224.
32. McKiernan KA, Kaufman JN, Kucera-Thompson J, Binder JR, (2003). A parametric manipulation of factors affecting task-induced deactivation in functional neuroimaging. J Cogn Neurosci 15: 394-408.
33. Mahmood D, Khanam R, Pillai KK, Akhtar M, (2012). Protective effects of histamine H3-receptor ligands in schizophrenic behaviors in experimental models. Pharmacol Rep 64: 191-204.
34. Manson SC, Wegner C, Filippi M, Barkhof F, Beckmann C, Ciccarelli O, et al. (2008). Impairment of movement-associated brain deactivation in multiple sclerosis: further evidence for a functional pathology of interhemispheric neuronal inhibition. Exp Brain Res 187: 25-31.
35. Marder SR, (2006). Drug initiatives to improve cognitive function. J Clin Psychiatry 67 (Suppl 9): 31-35. discussion 36-42.
36. Meltzer HY, Stahl SM, (1976). The dopamine hypothesis of schizophrenia: a review. Schizophr Bull 2: 19-76.
37. Meltzer HY, Park S, Kessler R, (1999). Cognition, schizophrenia, and the atypical antipsychotic drugs. Proc Natl Acad Sci U S A 96: 13591-13593.
38. Nakai T, Kitamura N, Hashimoto T, Kajimoto Y, Nishino N, Mita T, et al. (1991). Decreased histamine H1 receptors in the frontal cortex of brains from patients with chronic schizophrenia. Biol Psychiatry 30: 349-356.
39. Nauchi A, Sakai KL, (2009). Greater leftward lateralization of the inferior frontal gyrus in second language learners with higher syntactic abilities. Hum Brain Mapp 30: 3625-3635.
40. van Os J, Kapur S, (2009). Schizophrenia. Lancet 374: 635-645.
41. Owen AM, McMillan KM, Laird AR, Bullmore E, (2005). N-back working memory paradigm: a meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25: 46-59.
42. Pae CU, Juh R, Yoo SS, Choi BG, Lim HK, Lee C, et al. (2008). Verbal working memory dysfunction in schizophrenia: an FMRI investigation. Int J Neurosci 118: 1467-1487.
43. Prell GD, Green JP, Kaufmann CA, Khandelwal JK, Morrishow AM, Kirch DG, et al. (1995). Histamine metabolites in cerebrospinal fluid of patients with chronic schizophrenia: their relationships to levels of other aminergic transmitters and ratings of symptoms. Schizophr Res 14: 93-104.
44. de Rover M, Pironti VA, McCabe JA, Acosta-Cabronero J, Arana FS, Morein-Zamir S, et al. (2011). Hippocampal dysfunction in patients with mild cognitive impairment: a functional neuroimaging study of a visuospatial paired associates learning task. Neuropsychologia 49: 2060-2070.
45. van Ruitenbeek P, Vermeeren A, Smulders FT, Sambeth A, Riedel WJ, (2009). Histamine H1 receptor blockade predominantly impairs sensory processes in human sensorimotor performance. Br J Pharmacol 157: 76-85.
46. Sakai KL, Nauchi A, Tatsuno Y, Hirano K, Muraishi Y, Kimura M, et al. (2009). Distinct roles of left inferior frontal regions that explain individual differences in second language acquisition. Hum Brain Mapp 30: 2440-2452.
47. Schwartz JC, Arrang JM, Garbarg M, Pollard H, Ruat M, (1991). Histaminergic transmission in the mammalian brain. Physiol Rev 71: 1-51.
48. Smith EE, Jonides J, (1998). Neuroimaging analyses of human working memory. Proc Natl Acad Sci U S A 95: 12061-12068.
49. Szabadi E, Banqui Q, Banjar WMA, Gazzaz J, Langley RW, Bradshaw CM, (2009). Interactions between modafinil and betahistine on alertness and automatic functions in healthy volunteers. J Psychopharmacol 23 (6 Suppl.): A60.
50. Tighilet B, Trottier S, Mourre C, Chotard C, Lacour M, (2002). Betahistine dihydrochloride interaction with the histaminergic system in the cat: neurochemical and molecular mechanisms. Eur J Pharmacol 446: 63-73.
51. Tighilet B, Trottier S, Lacour M, (2005). Dose- and duration-dependent effects of betahistine dihydrochloride treatment on histamine turnover in the cat. Eur J Pharmacol 523: 54-63.
52. Vermeeren A, Ramaekers JG, Vuurman EFPM, Riedel WJ, (2006). Effects of histamine-3 receptor antagonsim on electrocortical arousal during vigilance performance in man. J Psychopharmacol 20 (5 Suppl.): A31.
53. Vohora D, Bhowmik M, (2012). Histamine H3 receptor antagonists/inverse agonists on cognitive and motor processes: relevance to Alzheimer's disease, ADHD, schizophrenia, and drug abuse. Front Syst Neurosci 6: 72.
54. Weiss EM, Siedentopf C, Golaszewski S, Mottaghy FM, Hofer A, Kremser C, et al. (2007). Brain activation patterns during a selective attention test-a functional MRI study in healthy volunteers and unmedicated patients during an acute episode of schizophrenia. Psychiatry Res 154: 31-40.
55. Westerink BH, Kawahara Y, De Boer P, Geels C, De Vries JB, Wikstrom HV, et al. (2001). Antipsychotic drugs classified by their effects on the release of dopamine and noradrenaline in the prefrontal cortex and striatum. Eur J Pharmacol 412: 127-138.
56. World Medical Association (1964, 2008). World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects.
57. Wu X, Chen K, Liu Y, Long Z, Wen X, Jin Z, et al. (2008). Ipsilateral brain deactivation specific to the nondominant hand during simple finger movements. Neuroreport 19: 483-486.